Our CEO, Dr. Tobias Kruse, and our Business Development Director, Dr. Matthias Roos, participated in the Bundesverband der Pharmazeutischen Industrie (German Federal Association of the Pharmaceutical Industry) Clinical Research Committee. Dr. Roos delivered an insightful speech on the future of clinical trials, emphasizing decentralization and patient-centricity. This speech underscored Trials24’s dedication to advancing and innovating in the clinical research landscape.
The event not only allowed us to share our expertise but also provided an invaluable opportunity to engage with other experts in the field. We express our gratitude to Bundesverband der Pharmazeutischen Industrie for this honor and the chance to contribute to shaping the future of clinical trials.
Photo from: LinkedIn Post by Climedo GmbH